ARCHIVES

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

This article is from The Cancer Letter archive.

Vol. 25 No. 06 | February 12, 1999

Download PDF Visit The Full Archive

Related Articles

Mendelsohn To Step Down As MD Anderson President

December 10, 2010

ASCO Recommends Beginning Palliative Care Alongside Standard Therapy in Metastatic NSCLC

February 24, 2012

DRCCA Committee, ACCC, DeVita Reach Agreement On CCOP

October 16, 1981

Arimidex Continues To Show Improvement Over Tamoxifen

December 27, 2002

NCI’s Otis Brawley Named Professor At Emory, Associate Director, Cancer Control, At Winship.

April 20, 2001

ProPAC Calls For Adjustments In For Tobacco Advertising Ban

July 25, 1986